Latest LCTX reports update at 2024-05-09: 2024-Q12023-Q42023-Q1
Lineage Cell Therapeutics logo
Lineage Cell Therapeutics LCTX
$ 1.18 1.72%

Lineage Cell Therapeutics P/E Ratio 2011-2024 | LCTX

Annual P/E Ratio Lineage Cell Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-40.1 -38.2 -8 -16.1 -13.3 -3.92 -17 8.75 -4.11 -7.45 -4.76 -10.4 -16.9

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
8.75 -40.1 -13.2